DV
Dividend Vision

DMII — Drugs Made In America Acquisition II Corp. Ordinary Shares

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)

Total return is 2.5% over the past 0.7 years, 12.0 points behind SPY at 14.5%.

DMII is a blank check company (special purpose acquisition company) incorporated to acquire, merge with, or engage in a business combination with an operating company, with a focus on the pharmaceutical or healthcare sector. The fund has no current operating business, generates no distributions, and carries no disclosed expense ratio or assets under management at this stage. This structure appeals to investors interested in gaining early exposure to potential healthcare industry consolidation or private company transitions to public markets.

DMII key facts

Asset type
Stock
Asset class
Equity
Inception date
12/03/2025
Last close
$10.13
Market cap
$642,096,000
Average volume
0.0
Beta
-0.0052
Payout ratio
0.0
P/E ratio
72.0
Forward P/E
0.0
EPS
$0.14